Wedbush analyst Robert Driscoll initiated coverage of Avalo Therapeutics (AVTX) with an Outperform rating and $18 price target Discover the ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here’s ...

U.S. defense stocks opened in the red on Thursday, Feb. 20 following reports that President Donald Trump’s administration has ...

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a research note issued to investors on Tuesday,RTT News reports. They ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...

Salesforce (NYSE:CRM) is set to report fiscal fourth-quarter results on Feb. 26 and Wedbush Securities said the Marc ...

The White House official said the Trump administration supports foreign companies investing and building in the U.S. but is ...

Palantir Technologies continues to surge, fueled by its AI platform, and saw its stock rise by 49%. Analysts, particularly ...

Roku stock is surging Friday after the streaming platform topped Q4 expectations and said it expects to be profitable in 2026 ...

Amazon's Q4 earnings beat analyst expectations, but AMZN stock sunk over 5% after hours. The call's discussion focused on AI ...